Literature DB >> 12135044

Paraneoplastic dysmotility: loss of interstitial cells of Cajal.

Darrell S Pardi1, Steven M Miller, Daniel L Miller, Lawrence J Burgart, Joseph H Szurszewski, Vanda A Lennon, Gianrico Farrugia.   

Abstract

Autoimmune impairment and destruction of the enteric nervous plexus are thought to play a central role in the pathogenesis of paraneoplastic motility disorders. We present a case of a small-cell lung carcinoma-related paraneoplastic motility disorder associated with abnormal interstitial cells of Cajal networks. Antibodies against c-Kit and protein gene product 9.5 were used to selectively stain interstitial cells of Cajal and the enteric nervous plexus, respectively. A 68-yr-old man presented with anorexia, early satiety, nausea, and weight loss. Investigations revealed gastroparesis, delayed small intestinal transit, and mediastinal lymphadenopathy. The patient was seropositive for type 1 antineuronal nuclear autoantibody and P/Q-type calcium channel antibody. Biopsy of mediastinal lymph nodes revealed metastatic small-cell carcinoma cells that were immunoreactive for c-Kit. Immunohistochemical staining of a full-thickness small intestinal biopsy revealed a relatively intact myenteric plexus but a sparse and disorganized interstitial cells of Cajal network. The histopathology of this case suggests that interstitial cells of Cajal may be a target in the pathogenesis of paraneoplastic motility disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135044     DOI: 10.1111/j.1572-0241.2002.05851.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

1.  A novel approach to paraneoplastic intestinal pseudo-obstruction.

Authors:  Ambuga Badari; Deborah Farolino; Eiad Nasser; Shahid Mehboob; David Crossland
Journal:  Support Care Cancer       Date:  2011-11-10       Impact factor: 3.603

2.  Acute gastric dilatation in a patient with spinal injury and multiple myeloma.

Authors:  Waheed Gul; Arif Qazi; Syed A Ali; Christopher Barde
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

Review 3.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 4.  Interstitial cells: regulators of smooth muscle function.

Authors:  Kenton M Sanders; Sean M Ward; Sang Don Koh
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

Review 5.  Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility.

Authors:  Madhusudan Grover; Michael Camilleri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

6.  Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility.

Authors:  E P Flanagan; Y A Saito; V A Lennon; A McKeon; R D Fealey; L A Szarka; J A Murray; A E Foxx-Orenstein; J C Fox; S J Pittock
Journal:  Neurogastroenterol Motil       Date:  2014-07-20       Impact factor: 3.598

7.  Chronic Intestinal Pseudoobstruction.

Authors:  Greg Lyford; Amy Foxx-Orenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

Review 8.  Enteric autoantibodies and gut motility disorders.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2008-06       Impact factor: 3.806

9.  Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.

Authors:  Rita A Mukhtar; Omar M Kattan; Hobart W Harris
Journal:  HPB Surg       Date:  2009-02-25

10.  Paraneoplastic oesophageal dysmotility-renal cell carcinoma presenting as dysphagia: a case report.

Authors:  Mahesh D Bhalme; Scott E Levison; Gurvinder S Banait
Journal:  Cases J       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.